Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsRhoVac AB announced that its Safety Monitoring Committee has conducted a planned interim safety review of its clinical Phase IIb trial in prostate cancer, known as BRaVac.
[RhoVac AB (PR Newswire, LLC)]
Sorry, but the selected Zotpress account can't be found.
